13.31
price down icon4.04%   -0.56
after-market アフターアワーズ: 13.37 0.06 +0.45%
loading
前日終値:
$13.87
開ける:
$14.15
24時間の取引高:
4.86M
Relative Volume:
1.00
時価総額:
$1.58B
収益:
$67.67M
当期純損益:
$-412.69M
株価収益率:
-3.4783
EPS:
-3.8266
ネットキャッシュフロー:
$-395.87M
1週間 パフォーマンス:
+0.83%
1か月 パフォーマンス:
+1.37%
6か月 パフォーマンス:
-1.92%
1年 パフォーマンス:
+57.70%
1日の値動き範囲:
Value
$13.20
$14.33
1週間の範囲:
Value
$11.76
$14.33
52週間の値動き範囲:
Value
$6.83
$28.25

Intellia Therapeutics Inc Stock (NTLA) Company Profile

Name
名前
Intellia Therapeutics Inc
Name
セクター
Healthcare (1106)
Name
電話
857-285-6200
Name
住所
40 ERIE STREET, CAMBRIDGE, MA
Name
職員
377
Name
Twitter
@intelliatweets
Name
次回の収益日
2026-05-14
Name
最新のSEC提出書
Name
NTLA's Discussions on Twitter

Compare NTLA vs VRTX, REGN, ARGX, ALNY, ONC

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
NTLA icon
NTLA
Intellia Therapeutics Inc
13.31 1.65B 67.67M -412.69M -395.87M -3.8266
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
424.36 109.34B 12.32B 4.34B 3.19B 16.86
REGN icon
REGN
Regeneron Pharmaceuticals Inc
702.27 74.35B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
794.70 50.44B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
301.11 39.78B 3.71B 313.75M 465.38M 2.2571
ONC icon
ONC
Beone Medicines Ltd Adr
297.49 33.02B 5.36B 287.73M 924.18M 2.5229

Intellia Therapeutics Inc Stock (NTLA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-03-02 アップグレード William Blair Mkt Perform → Outperform
2025-11-12 ダウングレード Wolfe Research Outperform → Peer Perform
2025-11-11 ダウングレード Evercore ISI Outperform → In-line
2025-11-07 ダウングレード JP Morgan Neutral → Underweight
2025-10-28 ダウングレード Bernstein Outperform → Mkt Perform
2025-10-28 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2025-10-27 ダウングレード Guggenheim Buy → Neutral
2025-10-27 ダウングレード William Blair Outperform → Mkt Perform
2025-10-06 アップグレード Citizens JMP Mkt Perform → Mkt Outperform
2025-04-21 アップグレード Wolfe Research Peer Perform → Outperform
2025-03-05 開始されました H.C. Wainwright Buy
2025-02-28 ダウングレード Goldman Neutral → Sell
2025-02-28 ダウングレード JP Morgan Overweight → Neutral
2025-01-27 ダウングレード Morgan Stanley Overweight → Equal-Weight
2024-02-23 ダウングレード Goldman Buy → Neutral
2024-02-15 開始されました Wolfe Research Peer Perform
2023-04-13 開始されました Canaccord Genuity Buy
2023-03-21 開始されました Bernstein Outperform
2023-03-14 アップグレード BMO Capital Markets Market Perform → Outperform
2023-02-01 開始されました Cantor Fitzgerald Overweight
2023-01-24 アップグレード Citigroup Sell → Neutral
2023-01-19 ダウングレード JMP Securities Mkt Outperform → Mkt Perform
2022-10-11 開始されました Morgan Stanley Overweight
2022-09-21 開始されました JP Morgan Overweight
2022-09-01 開始されました Citigroup Sell
2022-06-17 開始されました BMO Capital Markets Market Perform
2022-06-16 開始されました BofA Securities Buy
2022-04-28 開始されました Credit Suisse Outperform
2022-02-18 開始されました William Blair Outperform
2022-02-07 アップグレード Oppenheimer Perform → Outperform
2022-01-31 開始されました Cowen Outperform
2022-01-07 開始されました Piper Sandler Overweight
2021-10-05 開始されました Guggenheim Buy
2021-09-24 開始されました Stifel Buy
2021-06-28 繰り返されました H.C. Wainwright Buy
2021-06-11 開始されました H.C. Wainwright Buy
2021-05-07 アップグレード ROTH Capital Neutral → Buy
2021-05-04 開始されました RBC Capital Mkts Outperform
2021-03-04 開始されました JMP Securities Mkt Outperform
2020-12-22 ダウングレード Robert W. Baird Outperform → Neutral
2020-10-27 開始されました Truist Buy
2020-10-14 開始されました Wells Fargo Overweight
2020-09-18 開始されました Goldman Buy
2020-02-28 アップグレード Oppenheimer Perform → Outperform
2020-02-14 ダウングレード Wedbush Outperform → Neutral
2019-11-01 アップグレード Raymond James Mkt Perform → Outperform
2019-07-09 開始されました Robert W. Baird Outperform
2019-06-10 開始されました ROTH Capital Neutral
2019-05-03 アップグレード Wedbush Neutral → Outperform
2019-04-12 開始されました Evercore ISI Outperform
2018-11-02 ダウングレード Wedbush Outperform → Neutral
2018-10-29 開始されました Credit Suisse Neutral
2018-09-21 開始されました Raymond James Mkt Perform
2018-05-15 アップグレード Chardan Capital Markets Neutral → Buy
2018-03-08 開始されました JMP Securities Mkt Outperform
2017-11-01 繰り返されました Jefferies Buy
2017-06-22 再開されました Jefferies Buy
2017-03-28 開始されました Chardan Capital Markets Buy
2016-08-05 アップグレード Jefferies Hold → Buy
すべてを表示

Intellia Therapeutics Inc (NTLA) 最新ニュース

pulisher
May 05, 2026

Intellia Therapeutics Stock Is Down Nearly 95% From Its Record Highs but Cathie Wood Keeps Buying - Barchart

May 05, 2026
pulisher
May 05, 2026

Intellia Therapeutics Announces Investor Conference Participation on May 5, 2026 - geneonline.com

May 05, 2026
pulisher
May 05, 2026

Three Intellia fireside chats will stream live through June 3 - Stock Titan

May 05, 2026
pulisher
May 05, 2026

Intellia Therapeutics to Participate in Upcoming Investor Conferences - Yahoo Finance

May 05, 2026
pulisher
May 05, 2026

Shareholders of Intellia Therapeutics, Inc. Should Contact Levi - The National Law Review

May 05, 2026
pulisher
May 04, 2026

ARK Invest Increases Stake in Intellia Therapeutics (NTLA) Amid Sector Rotation - GuruFocus

May 04, 2026
pulisher
May 04, 2026

Intellia Therapeutics says its CRISPR-based treatment succeeds in pivotal trial - MSN

May 04, 2026
pulisher
May 04, 2026

Lonvo-z gene-editing therapy lowers HAE attacks by 87% in Phase 3 trial - Angioedema News

May 04, 2026
pulisher
May 04, 2026

Intellia Initiates Rolling BLA Submission For In Vivo CRISPR Therapy In Hereditary Angioedema - marketscreener.com

May 04, 2026
pulisher
May 03, 2026

NTLA stock rises 20% in 3 months: Here's what you should know - MSN

May 03, 2026
pulisher
May 03, 2026

Behavioral Patterns of NTLA and Institutional Flows - Stock Traders Daily

May 03, 2026
pulisher
May 03, 2026

Intellia Therapeutics shares slip despite strong phase 3 data - MSN

May 03, 2026
pulisher
May 03, 2026

symbol__ Stock Quote Price and Forecast - CNN

May 03, 2026
pulisher
May 02, 2026

NTLA jumps premarket on positive late-stage trial data for gene-editing therapy — retail says buy now before it’s too late - MSN

May 02, 2026
pulisher
May 02, 2026

Intellia Therapeutics, Inc. Sued for Securities Law Violations - GuruFocus

May 02, 2026
pulisher
May 01, 2026

Intellia Therapeutics (NTLA) Sees Major Purchase by ARK Investme - GuruFocus

May 01, 2026
pulisher
May 01, 2026

Cathie Wood’s ARK sells AMD stock, buys Roblox and Intellia - Investing.com

May 01, 2026
pulisher
May 01, 2026

Intellia Therapeutics Prices Public Equity Offering to Fund Pipeline - The Globe and Mail

May 01, 2026
pulisher
May 01, 2026

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

May 01, 2026
pulisher
May 01, 2026

43 new Intellia employees get stock awards worth 208,850 shares - Stock Titan

May 01, 2026
pulisher
May 01, 2026

Intellia Therapeutics prices $180M stock offering at discount - MSN

May 01, 2026
pulisher
May 01, 2026

Intellia Therapeutics | DEF 14A: Definitive information statements - Moomoo

May 01, 2026
pulisher
Apr 30, 2026

Intellia Therapeutics (NTLA) Is Down 15.1% After Phase 3 lonvo-z Data And $180M Equity RaiseHas The Bull Case Changed? - Yahoo Finance

Apr 30, 2026
pulisher
Apr 30, 2026

Intellia Therapeutics | SCHEDULE 13G: Others - Moomoo

Apr 30, 2026
pulisher
Apr 30, 2026

Intellia (NASDAQ: NTLA) equity sale boosts cash runway into 2028 - Stock Titan

Apr 30, 2026
pulisher
Apr 30, 2026

Intellia Therapeutics (NASDAQ: NTLA) sets 2026 virtual meeting on directors, pay and auditor - Stock Titan

Apr 30, 2026
pulisher
Apr 30, 2026

MSN Money - MSN

Apr 30, 2026
pulisher
Apr 30, 2026

NTLA Stock Draws Bulls After Phase 3 Gene-Editing Win - StocksToTrade

Apr 30, 2026
pulisher
Apr 30, 2026

[ARS] Intellia Therapeutics, Inc. SEC Filing - Stock Titan

Apr 30, 2026
pulisher
Apr 30, 2026

Vanguard (NTLA) files Schedule 13G reporting 5.03% ownership (5.95M) - Stock Titan

Apr 30, 2026
pulisher
Apr 30, 2026

Intellia Therapeutics | 424B5: Prospectus - Moomoo

Apr 30, 2026
pulisher
Apr 30, 2026

NTLA Forecast, Price Target & Analyst Ratings | INTELLIA THERAPEUTICS INC (NASDAQ:NTLA) - ChartMill

Apr 30, 2026
pulisher
Apr 30, 2026

ARK Investment Acquires 2.4 Million Shares of Intellia Therapeutics (NTLA) - GuruFocus

Apr 30, 2026
pulisher
Apr 29, 2026

$Intellia Therapeutics (NTLA.US)$ Hope u will give me good profit starr from today - Moomoo

Apr 29, 2026
pulisher
Apr 29, 2026

Intellia Therapeutics (NASDAQ: NTLA) offers 16.7M shares at $10.75 - Stock Titan

Apr 29, 2026
pulisher
Apr 29, 2026

NTLA Stock Slides As $150M Offering Signals Dilution Risk - timothysykes.com

Apr 29, 2026
pulisher
Apr 29, 2026

Vanguard Portfolio Management holds 5.3% of Intellia (NASDAQ: NTLA) - Stock Titan

Apr 29, 2026
pulisher
Apr 29, 2026

Intellia Therapeutics earnings in focus after gene editing breakthrough By Investing.com - Investing.com South Africa

Apr 29, 2026
pulisher
Apr 29, 2026

Intellia Therapeutics earnings in focus after gene editing breakthrough - Investing.com UK

Apr 29, 2026
pulisher
Apr 29, 2026

NTLA Stock Pressured As $150M Offering Tests Trader Nerves - StocksToTrade

Apr 29, 2026
pulisher
Apr 29, 2026

NTLA Secures $180 Million in Increased Common Stock Offering - GuruFocus

Apr 29, 2026
pulisher
Apr 29, 2026

Intellia Therapeutics (NTLA) Launches $180M Public Offering Amid Share Price Drop - GuruFocus

Apr 29, 2026
pulisher
Apr 29, 2026

Intellia Therapeutics stock tumbles on discounted offering - Investing.com

Apr 29, 2026
pulisher
Apr 29, 2026

Analysts Offer Insights on Healthcare Companies: Axsome Therapeutics (AXSM), Intellia Therapeutics (NTLA) and Incyte (INCY) - The Globe and Mail

Apr 29, 2026
pulisher
Apr 29, 2026

NTLA Stock Slips As $150M Equity Offering Raises Dilution Fears - timothysykes.com

Apr 29, 2026
pulisher
Apr 29, 2026

Intellia Files BLA After Lonvo-z Meets Phase 3 Endpoints - CRISPR Medicine News

Apr 29, 2026
pulisher
Apr 29, 2026

Intellia Therapeutics stock tumbles on discounted offering By Investing.com - Investing.com India

Apr 29, 2026
pulisher
Apr 29, 2026

Intellia Therapeutics stock tumbles on dilutive offering By Investing.com - Investing.com Canada

Apr 29, 2026
pulisher
Apr 29, 2026

Intellia Therapeutics stock tumbles on dilutive offering - Investing.com

Apr 29, 2026
pulisher
Apr 29, 2026

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Intellia Therapeutics (NTLA), Biogen (BIIB) and HCA Healthcare (HCA) - The Globe and Mail

Apr 29, 2026
pulisher
Apr 29, 2026

Intellia Therapeutics Announces Pricing of Public Offering of Common Stock - The Manila Times

Apr 29, 2026

Intellia Therapeutics Inc (NTLA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$28.32
price down icon 0.14%
$50.44
price up icon 0.48%
$95.50
price down icon 3.88%
$139.44
price down icon 0.41%
$147.21
price down icon 0.47%
ONC ONC
$297.49
price up icon 0.12%
大文字化:     |  ボリューム (24 時間):